Since many studies on the prognostic value of KRAS in NSCLC have focused on patients with either local or advanced disease, we also performed isolated subgroup analyses of patients with resected curative disease and advanced disease, in addition to the analyses of the whole cohort. Here, KRAS is linked to non-small cell lung carcinoma.